Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

Eli Lilly and Co. on Friday, Nov. 21 became the first health care company to surpass a $1 trillion market valuation, driven ...

Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...

Investing.com -- Eli Lilly stock dropped 5% on Wednesday after rival Novo Nordisk announced disappointing results from its ...

Stream Connecticut News for free, 24/7, wherever you are. The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific Sessions meeting ...

Bernstein just threw fresh fuel on Eli Lilly's (LLY) never-ending rally, as the firm lifted its price target on the stock to ...

It’s the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and ...

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...

UnitedHealth Group is working with Eli Lilly on a clinical trial that will study at-home infusions of the drugmaker’s COVID-19 antibody treatment. Eli Lilly’s antibody drug, bamlanivimab, has received ...

Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...

Eli Lilly’s remarkable outperformance within the pharmaceutical sector hasn’t tempered enthusiasm, analysts are still ...